NO20062918L - Anvendelse av antibiotika som vaksineadjuvanser - Google Patents
Anvendelse av antibiotika som vaksineadjuvanserInfo
- Publication number
- NO20062918L NO20062918L NO20062918A NO20062918A NO20062918L NO 20062918 L NO20062918 L NO 20062918L NO 20062918 A NO20062918 A NO 20062918A NO 20062918 A NO20062918 A NO 20062918A NO 20062918 L NO20062918 L NO 20062918L
- Authority
- NO
- Norway
- Prior art keywords
- adjuvant
- azalide
- vaccine
- antibiotics
- antimicrobial agent
- Prior art date
Links
- 239000012646 vaccine adjuvant Substances 0.000 title abstract 2
- 229940124931 vaccine adjuvant Drugs 0.000 title abstract 2
- 239000003242 anti bacterial agent Substances 0.000 title 1
- 229940088710 antibiotic agent Drugs 0.000 title 1
- 239000002671 adjuvant Substances 0.000 abstract 5
- 239000004599 antimicrobial Substances 0.000 abstract 3
- 229960005486 vaccine Drugs 0.000 abstract 2
- 239000013566 allergen Substances 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000001717 pathogenic effect Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/116—Polyvalent bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US52409703P | 2003-11-21 | 2003-11-21 | |
| PCT/IB2004/003694 WO2005049081A1 (en) | 2003-11-21 | 2004-11-08 | The use of anti biotics as vaccine adjuvants |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20062918L true NO20062918L (no) | 2006-08-21 |
Family
ID=34619630
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20062918A NO20062918L (no) | 2003-11-21 | 2006-06-21 | Anvendelse av antibiotika som vaksineadjuvanser |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20070141086A1 (pt) |
| EP (1) | EP1689434A1 (pt) |
| JP (1) | JP2007512312A (pt) |
| KR (1) | KR100785601B1 (pt) |
| CN (1) | CN1882360A (pt) |
| AR (1) | AR047728A1 (pt) |
| AU (1) | AU2004290982B2 (pt) |
| BR (1) | BRPI0416205A (pt) |
| CA (1) | CA2546195A1 (pt) |
| IL (1) | IL175373A0 (pt) |
| MX (1) | MXPA06005639A (pt) |
| NO (1) | NO20062918L (pt) |
| RU (1) | RU2322241C2 (pt) |
| TW (1) | TW200526245A (pt) |
| WO (1) | WO2005049081A1 (pt) |
| ZA (1) | ZA200603065B (pt) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070077256A1 (en) | 1999-11-19 | 2007-04-05 | Los Angeles Biomedical Research Institute | Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis and other infectious agents |
| IL152486A0 (en) | 2002-10-25 | 2003-05-29 | Meir Eini | Alcohol-free cosmetic and pharmaceutical foam carrier |
| US7700076B2 (en) | 2002-10-25 | 2010-04-20 | Foamix, Ltd. | Penetrating pharmaceutical foam |
| US9668972B2 (en) | 2002-10-25 | 2017-06-06 | Foamix Pharmaceuticals Ltd. | Nonsteroidal immunomodulating kit and composition and uses thereof |
| US20080138296A1 (en) | 2002-10-25 | 2008-06-12 | Foamix Ltd. | Foam prepared from nanoemulsions and uses |
| AU2003279493B2 (en) | 2002-10-25 | 2009-08-20 | Foamix Pharmaceuticals Ltd. | Cosmetic and pharmaceutical foam |
| US9265725B2 (en) | 2002-10-25 | 2016-02-23 | Foamix Pharmaceuticals Ltd. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
| US10117812B2 (en) | 2002-10-25 | 2018-11-06 | Foamix Pharmaceuticals Ltd. | Foamable composition combining a polar solvent and a hydrophobic carrier |
| US7704518B2 (en) | 2003-08-04 | 2010-04-27 | Foamix, Ltd. | Foamable vehicle and pharmaceutical compositions thereof |
| FR2896416B1 (fr) * | 2006-01-24 | 2010-08-13 | Vetoquinol | Composition anti-infectieuse comprenant un compose de type pyrido (3,2,1-ij)-benzoxadiazine |
| US20080260655A1 (en) | 2006-11-14 | 2008-10-23 | Dov Tamarkin | Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses |
| US8636982B2 (en) | 2007-08-07 | 2014-01-28 | Foamix Ltd. | Wax foamable vehicle and pharmaceutical compositions thereof |
| WO2009069006A2 (en) | 2007-11-30 | 2009-06-04 | Foamix Ltd. | Foam containing benzoyl peroxide |
| WO2009072007A2 (en) | 2007-12-07 | 2009-06-11 | Foamix Ltd. | Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof |
| AP2010005296A0 (en) * | 2007-12-21 | 2010-06-30 | Glaxosmithkline Biolog Sa | Vaccines for malaria |
| US20120087872A1 (en) | 2009-04-28 | 2012-04-12 | Foamix Ltd. | Foamable Vehicles and Pharmaceutical Compositions Comprising Aprotic Polar Solvents and Uses Thereof |
| CA2769625C (en) | 2009-07-29 | 2017-04-11 | Foamix Ltd. | Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses |
| WO2011013008A2 (en) | 2009-07-29 | 2011-02-03 | Foamix Ltd. | Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses |
| CN102686205A (zh) | 2009-10-02 | 2012-09-19 | 弗艾米克斯有限公司 | 局部四环素组合物 |
| US9849142B2 (en) | 2009-10-02 | 2017-12-26 | Foamix Pharmaceuticals Ltd. | Methods for accelerated return of skin integrity and for the treatment of impetigo |
| WO2011092185A1 (en) * | 2010-01-28 | 2011-08-04 | Universiteit Gent | Salmonella vaccine |
| CN103998056B (zh) | 2011-07-22 | 2017-09-12 | 诺瓦蒂格姆疗法有限公司 | 用于接种抗金黄色葡萄球菌疫苗的方法和组合物 |
| JP6348967B2 (ja) * | 2013-03-14 | 2018-06-27 | ワン、ロンフ | 制御性ｔ細胞機能を調節する方法および組成物 |
| EA030005B1 (ru) | 2013-03-15 | 2018-06-29 | Лос-Анджелес Биомедикал Ресерч Институт Эт Харбор-Укла Медикал Центер | Композиции и способы лечения грибковых и бактериальных патогенов |
| CN103127098B (zh) * | 2013-03-22 | 2014-05-14 | 于法周 | 一种含有克拉维酸或其盐的抗癌药物组合物及制药用途 |
| EP2926815A1 (en) * | 2014-04-03 | 2015-10-07 | Institut Curie | New derivatives of cephalosporin for treating cancer |
| WO2016065525A1 (zh) * | 2014-10-28 | 2016-05-06 | 湘北威尔曼制药股份有限公司 | 一种氧代哌嗪酰胺类化合物的用途 |
| CN105616414B (zh) * | 2014-10-28 | 2019-03-05 | 湘北威尔曼制药股份有限公司 | 一种氧代哌嗪酰胺类化合物的新用途 |
| CN104546863B (zh) * | 2015-02-09 | 2016-09-14 | 江苏澳格姆生物科技有限公司 | 头孢噻吩钠在制备抑制肿瘤细胞转移和扩散的药物中的应用 |
| US11278616B2 (en) * | 2015-08-06 | 2022-03-22 | Nitto Denko Corporation | Immunity induction promoting composition, and vaccine pharmaceutical composition |
| WO2017116049A1 (ko) * | 2015-12-31 | 2017-07-06 | 경북대학교 산학협력단 | 설폰아마이드계 화합물을 유효성분으로 포함하는 암의 치료 및 전이 억제용 약학적 조성물 |
| JP2019507759A (ja) | 2016-03-09 | 2019-03-22 | ロサンゼルス バイオメディカル リサーチ インスティテュート アット ハーバー− ユーシーエルエー メディカル センター | 外陰部膣カンジダ症の予防及び治療で使用するための方法及びキット |
| MX2017011630A (es) | 2016-09-08 | 2018-09-25 | Foamix Pharmaceuticals Ltd | Composiciones y metodos para tratar rosacea y acne. |
| CN110302376A (zh) * | 2019-04-22 | 2019-10-08 | 荆门市动物疫病预防控制中心 | 一种禽流感疫苗佐剂及应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5929086A (en) * | 1996-05-10 | 1999-07-27 | Pharmacia & Upjohn Company | Topical administration of antimicrobial agents for the treatment of systemic bacterial diseases |
| HN1998000086A (es) * | 1997-06-11 | 1999-03-08 | Pfizer Prod Inc | Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos. |
| US6339063B1 (en) * | 1997-09-10 | 2002-01-15 | Merck & Co., Inc. | 9a-azalides as veterinary antimicrobial agents |
| UA70972C2 (uk) * | 1998-11-20 | 2004-11-15 | Пфайзер Продактс Інк. | 13-членні азаліди і їх застосування як антибіотиків |
-
2004
- 2004-11-08 BR BRPI0416205-6A patent/BRPI0416205A/pt not_active IP Right Cessation
- 2004-11-08 AU AU2004290982A patent/AU2004290982B2/en not_active Expired - Fee Related
- 2004-11-08 JP JP2006540643A patent/JP2007512312A/ja not_active Withdrawn
- 2004-11-08 MX MXPA06005639A patent/MXPA06005639A/es not_active Application Discontinuation
- 2004-11-08 EP EP04798833A patent/EP1689434A1/en not_active Withdrawn
- 2004-11-08 CA CA002546195A patent/CA2546195A1/en not_active Abandoned
- 2004-11-08 CN CNA2004800341547A patent/CN1882360A/zh active Pending
- 2004-11-08 WO PCT/IB2004/003694 patent/WO2005049081A1/en active Application Filing
- 2004-11-08 US US10/595,784 patent/US20070141086A1/en not_active Abandoned
- 2004-11-08 RU RU2006117339/15A patent/RU2322241C2/ru not_active IP Right Cessation
- 2004-11-08 KR KR1020067009852A patent/KR100785601B1/ko not_active IP Right Cessation
- 2004-11-19 AR ARP040104279A patent/AR047728A1/es not_active Application Discontinuation
- 2004-11-19 TW TW093135705A patent/TW200526245A/zh unknown
-
2006
- 2006-04-18 ZA ZA200603065A patent/ZA200603065B/xx unknown
- 2006-05-01 IL IL175373A patent/IL175373A0/en unknown
- 2006-06-21 NO NO20062918A patent/NO20062918L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA06005639A (es) | 2006-08-17 |
| IL175373A0 (en) | 2006-09-05 |
| KR20060091001A (ko) | 2006-08-17 |
| EP1689434A1 (en) | 2006-08-16 |
| RU2006117339A (ru) | 2007-12-10 |
| RU2322241C2 (ru) | 2008-04-20 |
| AU2004290982A1 (en) | 2005-06-02 |
| WO2005049081A1 (en) | 2005-06-02 |
| JP2007512312A (ja) | 2007-05-17 |
| AR047728A1 (es) | 2006-02-15 |
| US20070141086A1 (en) | 2007-06-21 |
| KR100785601B1 (ko) | 2007-12-14 |
| CA2546195A1 (en) | 2005-06-02 |
| ZA200603065B (en) | 2007-08-29 |
| BRPI0416205A (pt) | 2006-12-26 |
| CN1882360A (zh) | 2006-12-20 |
| TW200526245A (en) | 2005-08-16 |
| AU2004290982B2 (en) | 2008-06-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20062918L (no) | Anvendelse av antibiotika som vaksineadjuvanser | |
| NO20061912L (no) | Vaksinesammensetninger omfattende et interleukin 18 og saponin adjuvant system | |
| BRPI0410503B8 (pt) | composição tópica e uso da composição | |
| NO20055894L (no) | Fremgangsmater og blandinger for behandling av amyloidrelatertere sykdommer | |
| DK1187629T3 (da) | Adjuvanssammensætning omfattende saponin og et immunostimulerende oligonucleotid | |
| SE0102315D0 (sv) | Compounds | |
| EA200801275A1 (ru) | Стабилизированные составы карбоната лантана | |
| NO20061911L (no) | Immunogene sammensetninger | |
| BRPI0418251A (pt) | fosfonatos, monofosfonamidatos, bisfosfonamidatos para o tratamento de doenças virais | |
| ECSP034916A (es) | Oxazolidinonas substituidas para terapia de combinacion | |
| NO20052787L (no) | N-alkyl-4-metylenamino-3-hydroksy-2-pyridoner som antimikrobielle midler | |
| AR109263A2 (es) | Composición que comprende moxidectina | |
| TR200400363T4 (tr) | Antibiyotikten / Antibiyotiklerden oluşan bir preparatın imalatı ve kullanımı | |
| EA200600280A1 (ru) | Композиции на основе производных липопептидных антибиотиков и способы их применения | |
| UY28313A1 (es) | Nonadepsipeptidos acilados | |
| AR053775A1 (es) | Nonadepsipeptidos acilados ii | |
| ECSP045397A (es) | 6-ALQUILIDEN-PENEMS BICÍCLICOS COMO INHIBIDORES DE LAS b-LACTAMASAS | |
| CY1109187T1 (el) | Νεα μακρολιδια | |
| ATE417856T1 (de) | Motilidverbindungen | |
| TR200401120T4 (tr) | Endoparazit öldürücü jel bileşimi | |
| ATE433459T1 (de) | Desoxo-nonadepsipeptide | |
| NO20054346L (no) | Sammensetninger og fremgangsmater for forebygging og behandling av endotoksinrelaterte sykdommer og tilstander | |
| UY28542A1 (es) | Amidas macrocíclicas antibacterianas | |
| CR9073A (es) | Coadministracion de tigeciclina y digoxin | |
| ECSP045405A (es) | Penems 6-alquiliden heterotriciclil como inhibidores de la beta lactamasa |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |